These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rayleigh light scattering detection of three α1-adrenoceptor antagonists coupled with high performance liquid chromatograph. Li AP; Peng H; Peng JD; Zhou MQ; Zhang J Spectrochim Acta A Mol Biomol Spectrosc; 2015 Aug; 147():178-84. PubMed ID: 25840026 [TBL] [Abstract][Full Text] [Related]
3. Determination of terazosin in human plasma, using high-performance liquid chromatography with fluorescence detection. Sekhar EC; Rao TR; Sekhar KR; Naidu MU; Shobha JC; Rani PU; Kumar TV; Kumar VP J Chromatogr B Biomed Sci Appl; 1998 Jun; 710(1-2):137-42. PubMed ID: 9686880 [TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatographic analysis and pharmacokinetics of terazosin in healthy volunteers. Kang BC; Yang CQ; Rhee JE; Suh OK; Shin WG Res Commun Mol Pathol Pharmacol; 2001; 110(5-6):371-7. PubMed ID: 12889528 [TBL] [Abstract][Full Text] [Related]
5. Determination of alpha 1-adrenoceptor antagonists in plasma by radioreceptor assay. Yamada S; Tanaka C; Suzuki M; Ohkura T; Kimura R; Kawabe K J Pharm Biomed Anal; 1996 Jan; 14(3):289-94. PubMed ID: 8851753 [TBL] [Abstract][Full Text] [Related]
6. Fluorescent quantification of terazosin hydrochloride content in human plasma and tablets using second-order calibration based on both parallel factor analysis and alternating penalty trilinear decomposition. Zou HY; Wu HL; OuYang LQ; Zhang Y; Nie JF; Fu HY; Yu RQ Anal Chim Acta; 2009 Sep; 650(1):143-9. PubMed ID: 19720185 [TBL] [Abstract][Full Text] [Related]
7. Enantioselective determination of terazosin in human plasma by normal phase high-performance liquid chromatography-electrospray mass spectrometry. Zavitsanos AP; Alebic-Kolbah T J Chromatogr A; 1998 Jan; 794(1-2):45-56. PubMed ID: 9491556 [TBL] [Abstract][Full Text] [Related]
8. Effect of age on pharmacokinetics of and blood pressure responses to prazosin and terazosin. McNeil JJ; Drummer OH; Conway EL; Workman BS; Louis WJ J Cardiovasc Pharmacol; 1987 Aug; 10(2):168-75. PubMed ID: 2441167 [TBL] [Abstract][Full Text] [Related]
9. Validation of a solid-phase extraction high-performance liquid chromatographic assay for doxazosin. Jackman GP; Colagrande F; Louis WJ J Chromatogr; 1991 May; 566(1):234-8. PubMed ID: 1679435 [TBL] [Abstract][Full Text] [Related]
10. Ion-exchange high-performance liquid chromatography in drug assay in biological fluids. III. Propranolol, nadolol and prazosin. Piotrovskii VK; Belolipetskaya VG; El'man AR; Metelitsa VI J Chromatogr; 1983 Dec; 278(2):469-74. PubMed ID: 6668330 [No Abstract] [Full Text] [Related]
11. Validated specific HPLC methods for determination of prazosin, terazosin and doxazosin in the presence of degradation products formed under ICH-recommended stress conditions. Bakshi M; Ojha T; Singh S J Pharm Biomed Anal; 2004 Jan; 34(1):19-26. PubMed ID: 14738915 [TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatography using electrochemical detection for the determination of prazosin in biological samples. Rathinavelu A; Malave A J Chromatogr B Biomed Appl; 1995 Aug; 670(1):177-82. PubMed ID: 7493078 [TBL] [Abstract][Full Text] [Related]
13. Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics. Taguchi K; Schäfers RF; Michel MC Br J Clin Pharmacol; 1998 Jan; 45(1):49-55. PubMed ID: 9489594 [TBL] [Abstract][Full Text] [Related]
14. Determination of tiodazosin concentrations in human plasma with a fluorescence high-performance liquid chromatographic method. Forgue ST; Van Harken DR; Smyth RD J Chromatogr; 1985 Jul; 342(1):221-7. PubMed ID: 4044753 [No Abstract] [Full Text] [Related]
15. Improved high-performance liquid chromatographic analysis of terazosin in human plasma. Cheah PY; Yuen KH; Liong ML J Chromatogr B Biomed Sci Appl; 2000 Aug; 745(2):439-43. PubMed ID: 11043762 [TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic determination of alfuzosin in biological fluids with fluorimetric detection and large-volume injection. Guinebault P; Broquaire M; Colafranceschi C; Thénot JP J Chromatogr; 1986 Feb; 353():361-9. PubMed ID: 2871035 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic drug monitoring of alpha-blocker, prazosin]. Mikami H; Ogihara T Nihon Rinsho; 1990 Feb; 48 Suppl():1143-5. PubMed ID: 1972419 [No Abstract] [Full Text] [Related]
18. Differential pulse polarographic determination of prazosin hydrochloride in tablets. Altiokka G; Tunçel M Pharmazie; 1997 May; 52(5):401-2. PubMed ID: 9183792 [No Abstract] [Full Text] [Related]
19. Accurate mass measurement of synthetic analogues of prazosine by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry. Andalò C; Bocchini P; Pozzi R; Galletti GC Rapid Commun Mass Spectrom; 2001; 15(9):665-9. PubMed ID: 11319786 [TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatographic determination of prazosin in human plasma, whole blood and urine. Lin ET; Baughman RA; Benet LZ J Chromatogr; 1980 Sep; 183(3):367-71. PubMed ID: 7419656 [No Abstract] [Full Text] [Related] [Next] [New Search]